Elizaveta Alperina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elizaveta Alperina has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Galina Idova
Russian Academy of Medical Sciences
2 shared publications Elena Zhukova
Federal State Budgetary Scientific Institution "Scientific Research Institute of Physiology and Basic Medicine", Timakova Street, 4, Novosibirsk, Russia
1 shared publicationIrina Plyusnina
Federal Research Center "Institute of Cytology and Genetics", Siberian Branch of the Russian Academy of Sciences, Lavrentyev Avenue, 10, 630090 Novosibirsk, Russia; Novosibirsk State University, Pirogova Street, 2, 630090 Novosibirsk, Russia
1 shared publicationLidia Devoino
State Research Institute of Physiology of the Russian Academy of Medical Science, Siberian Branch, Novosibirsk, Timakova, Russian Federation
1 shared publicationMargarita Cheido
State Research Institute of Physiology of the Russian Academy of Medical Science, Siberian Branch, Novosibirsk, Timakova, Russian Federation
1 shared publicationMargarita Gevorgyan
Federal State Budgetary Scientific Institution "Scientific Research Institute of Physiology and Basic Medicine", Timakova Street, 4, Novosibirsk, Russia
1 shared publication
Latest Publications
- 1 November 2015
- Published by Elsevier in Neuroscience Letters
- Vol. 609, 103-108
Immune reactivity in rats selected for the enhancement or elimination of aggressiveness towards humans
- 1 November 2015
- Published by Elsevier in Neuroscience Letters
- Vol. 609, 103-108
Immune reactivity in rats selected for the enhancement or elimination of aggressiveness towards humans
- 1 January 2003
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 113 (10) , 1381-1394
EVIDENCE FOR A ROLE OF DOPAMINERGIC MECHANISMS IN THE IMMUNOSTIMULATING EFFECT OF µ-OPIOID RECEPTOR AGONIST DAGO
The present study demonstrates that: (1) activation of µ-opioid receptors by systemic administration of a highly selective agonist DAGO (100 µg/kg) results in a significant increase in the number of plaque- and rosette-forming cells in the spleen of CBA mice as well as Wistar rats on the 5th day following sheep red blood cells (5 2 108) immunization, (2) the immunostimulatory effect of DAGO is mediated by central mechanisms including the hypothalamus-hypophysis complex; (3) the postsynaptic dopamine (DA) receptors of D2 type are involved in the DAGO-induced immunostimulation since the combined treatment of animals with haloperidol (2 mg/kg), a blocker of DA D2 receptors, and DAGO abolished this effect; (4) the nuclei caudatus and accumbens of the nigrostriatal and mesolimbic DAergic systems, respectively, are implicated in the immune response stimulation caused by DAGO.
- 1 January 2003
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 113 (10) , 1381-1394
EVIDENCE FOR A ROLE OF DOPAMINERGIC MECHANISMS IN THE IMMUNOSTIMULATING EFFECT OF µ-OPIOID RECEPTOR AGONIST DAGO
The present study demonstrates that: (1) activation of µ-opioid receptors by systemic administration of a highly selective agonist DAGO (100 µg/kg) results in a significant increase in the number of plaque- and rosette-forming cells in the spleen of CBA mice as well as Wistar rats on the 5th day following sheep red blood cells (5 2 108) immunization, (2) the immunostimulatory effect of DAGO is mediated by central mechanisms including the hypothalamus-hypophysis complex; (3) the postsynaptic dopamine (DA) receptors of D2 type are involved in the DAGO-induced immunostimulation since the combined treatment of animals with haloperidol (2 mg/kg), a blocker of DA D2 receptors, and DAGO abolished this effect; (4) the nuclei caudatus and accumbens of the nigrostriatal and mesolimbic DAergic systems, respectively, are implicated in the immune response stimulation caused by DAGO.